Cochlear | COH - Operating Profit

Stock Price
198.61
Daily Change
1.61 0.81%
Monthly
-28.37%
Yearly
-24.43%
Q1 Forecast
194.59

Cochlear reported AUD125.55M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Ansell USD 58.65M 19.15M Jun/2024
Avita Medical AUD -11.15M 1.19M Jun/2025
Cochlear AUD 125.55M 149.05M Jun/2025
CSL USD 666M 1.31B Jun/2025
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Healius AUD -22.6M 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Mesoblast USD -42.11M 21.69M Jun/2025
Monash IVF AUD 7.89M 19.8M Jun/2025
Nanosonics AUD 5.3M 3.4M Jun/2025
Polynovo AUD 513K 902K Jun/2024
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
Regis Healthcare AUD 12.76M 76.64M Jun/2025
ResMed USD 500.3M 37.95M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Somnomed AUD -4.16M 1.28M Jun/2023
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025